Edition:
United States

Insider Trading: Albany Molecular Research Inc (AMRI.O)

AMRI.O on Nasdaq

18.81USD
26 May 2017
Change (% chg)

$0.41 (+2.23%)
Prev Close
$18.40
Open
$18.36
Day's High
$18.98
Day's Low
$17.94
Volume
764,252
Avg. Vol
634,851
52-wk High
$19.35
52-wk Low
$12.51

All Insider Trades
Trading Date Name Title Type Shares Traded Price
9 May 2017

Ryan (Una S)

Director Buy 5,000 $14.47
1 Mar 2017

Boyer (Milton)

Officer Sell 277 $14.52
1 Mar 2017

Henderson (Lori M)

General Counsel Sell 432 $14.52
1 Mar 2017

Hagen (Steven R)

Officer Sell 350 $14.52
1 Mar 2017

Svokos (George)

Chief Operating Officer Sell 361 $14.52
1 Mar 2017

Ladin (Felicia I)

Chief Financial Officer Sell 361 $14.52
1 Mar 2017

Conway (Christopher M)

Officer Sell 271 $14.52
16 Feb 2017

Ladin (Felicia I)

Chief Financial Officer Sell 2,097 $18.71
7 Feb 2017

Fine (Margalit)

Officer Buy 3,312 $0.00
7 Feb 2017

Hagen (Steven R)

Officer Buy 5,975 $0.00
7 Feb 2017

Hagen (Kenneth Paul CPA)

Director Buy 3,802 $0.00
7 Feb 2017

Marth (William S)

Chief Executive Officer Buy 20,383 $0.00
7 Feb 2017

Gutierrez (Fuentes Luis Gerardo)

Director Buy 3,802 $0.00
7 Feb 2017

Hagen (Steven R)

Officer Buy 4,484 $0.00
7 Feb 2017

Henderson (Lori M)

General Counsel Buy 6,747 $0.00
7 Feb 2017

Marth (William S)

Chief Executive Officer Buy 27,159 $0.00
7 Feb 2017

Maddaluna (Anthony J)

Director Buy 3,802 $0.00
7 Feb 2017

Boyer (Milton)

Officer Buy 6,090 $0.00
7 Feb 2017

D'Ambra (Thomas E)

Chairman of the Board Buy 3,802 $0.00
7 Feb 2017

Henderson (Lori M)

General Counsel Buy 8,990 $0.00
7 Feb 2017

Roth (Arthur J)

Director Buy 3,802 $0.00
7 Feb 2017

Svokos (George)

Chief Operating Officer Buy 8,663 $0.00
7 Feb 2017

Ladin (Felicia I)

Chief Financial Officer Buy 7,134 $0.00
7 Feb 2017

O'Connor (Kevin)

Director Buy 3,802 $0.00
7 Feb 2017

Conway (Christopher M)

Officer Buy 3,210 $0.00

Institutional Holders

% Shares Owned: 75.41%
# of Holders: 203
Total Shares Held: 32,373,667
3 Mo. Net Change: 854,722
# New Positions: 22
# Closed Positions: 13
# Increased Positions: 80
# Reduced Positions: 77
# Net Buyers: 3

Officers & Directors

Name Age Since Current Position

Thomas D' Ambra

59 2013 Non-Executive Chairman of the Board

William Marth

60 2014 President, Chief Executive Officer, Director

Felicia Ladin

43 2015 Chief Financial Officer, Senior Vice President, Treasurer

Lori Henderson

53 2011 Senior Vice President, General Counsel, Secretary

Christopher Conway

2015 Senior Vice President - Discovery and Development and Global Commercial Sales

Milton Boyer

2015 Senior Vice President - Drug Product Manufacturing

Steven Hagen

54 2012 Senior Vice President - Manufacturing and Pharmaceuticals

George Svokos

57 2015 Chief Commercial Officer and Senior Vice President, API

Jimmy Wang

2015 Chief Information Officer

Una Ryan

73 2010 Lead Independent Director

David Deming

62 2016 Director

Gerardo Gutierrez

2015 Director

Kenneth Hagen

2016 Director

Anthony Maddaluna

63 2016 Director

Fernando Napolitano

49 2016 Director

Kevin O' Connor

60 2000 Independent Director

Arthur Roth

75 2003 Independent Director